Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.
CK2 is a pivotal pro-survival protein kinase in multiple myeloma that may likely impinge on bortezomib-regulated cellular pathways. In the present study, we investigated CK2 expression in multiple myeloma and mantle cell lymphoma, two bortezomib-responsive B cell tumors, as well as its involvement i...
Main Authors: | Sabrina Manni, Alessandra Brancalion, Elisa Mandato, Laura Quotti Tubi, Anna Colpo, Marco Pizzi, Rocco Cappellesso, Fortunato Zaffino, Speranza Antonia Di Maggio, Anna Cabrelle, Filippo Marino, Renato Zambello, Livio Trentin, Fausto Adami, Carmela Gurrieri, Gianpietro Semenzato, Francesco Piazza |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24086494/?tool=EBI |
Similar Items
-
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
by: Colpo Anna, et al.
Published: (2010-10-01) -
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
by: Zaira Spinello, et al.
Published: (2021-04-01) -
Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research
by: Sabrina Manni, et al.
Published: (2020-05-01) -
Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib
by: Ayse Tarbin Jannuzzi, et al.
Published: (2020-05-01) -
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
by: Renato Zambello, et al.
Published: (2020-03-01)